Updated:
Yokohama Capital
Yokohama Capital — the Bank of Yokohama's private capital arm since 1984 — invests venture, growth, and turnaround capital into SMEs across Kanagawa and...
Yokohama Capital
Founded in 1984 as a private capital arm of the Bank of Yokohama, Yokohama Capital provides venture, growth, and turnaround capital to small and medium-sized enterprises in Kanagawa Prefecture and the Tokyo metropolitan area. The firm's investment capacity flows through funds it manages in partnership with its banking parent, creating a permanent capital base tied to the region's corporate banking relationships. The firm blends early-stage venture with succession buyouts and business turnarounds, spanning IT, healthcare, mobility, and industrial robotics. Publicly announced positions include digital-health venture Varinos, stablecoin platform JPYC, drug-discovery firms Eurus Therapeutics and Reborna Bioscience, aviation-software company NABLA Mobility, legal-tech provider GVA TECH, and robotics developer LexxPluss. The portfolio reflects a pragmatic, sector-agnostic mandate focused on owner-operated businesses and technology companies rooted in Japan's second-largest metropolitan economy. Scale and team metrics are not publicly reported, though the firm's deal cadence — roughly a dozen new and follow-on investments annually visible from its news feed — signals steady deployment activity. In May 2026, Yokohama Capital disclosed a new investment in genomic-testing company Varinos, extending a healthcare-technology streak that also saw commitments to biotech startups throughout 2025. The firm announced a portfolio exit via the public listing of legal-tech company GVA TECH in December 2024. Yokohama Capital's structural advantage lies in its origination model: it leverages the Bank of Yokohama's regional client network to surface succession-driven and growth-equity deals that are rarely competed for by Tokyo-centric funds. This embedded banking relationship gives the firm a distinct role as a regional consolidator and SME-transition specialist, operating at the intersection of venture capital and traditional bank-led corporate finance.
General information
Firm type
Private Equity
Year founded
1984
AUM
Undisclosed
Location
Region
Asia
Country
Japan
City
Yokohama
Corporate office
Yokohama city, Kanagawa Prefecture, Japan
Sector focus
Frequently asked questions
How is Yokohama Capital related to the Bank of Yokohama?
Yokohama Capital is the private capital arm of the Bank of Yokohama. The firm manages funds operated alongside its banking parent, using the bank's regional corporate relationships to source investment opportunities and fund commitments. Its investment mandate is separate from the bank's lending activities, but the parent relationship provides a permanent capital base and proprietary deal flow centered on Kanagawa Prefecture and the Tokyo metropolitan area.
What investment stages does Yokohama Capital target?
The firm targets venture (general), growth and late-stage expansion, succession-driven buyouts, turnarounds, and PIPE transactions. Its publicly announced portfolio confirms activity across early-stage technology companies and established small-to-medium enterprises, reflecting a mandate that couples venture-style investing with bank-originated corporate finance.
Which sectors does Yokohama Capital invest in?
According to the firm, sectors include IT, services, and healthcare. Announced portfolio companies span digital-health diagnostics (Varinos), drug-discovery biotech (Eurus Therapeutics, Reborna BioScience), legal technology (GVA TECH), aviation software (NABLA Mobility), and industrial robotics (LexxPluss). The portfolio does not signal a single-sector concentration, consistent with the firm's stated broad industry appetite.
Does Yokohama Capital operate only in Kanagawa, or does it invest nationwide?
The firm emphasizes Kanagawa Prefecture and the Tokyo metropolitan area as its investment geography. While its parent bank's footprint extends across Japan's second-largest economic zone, Yokohama Capital's primary origination is tied to that regional network, and all publicly named portfolio companies are Japanese entities.
Does Yokohama Capital participate in fund commitments or only direct deals?
Yokohama Capital operates through funds it manages alongside the Bank of Yokohama, deploying capital directly into portfolio companies rather than commitments to third-party funds. The firm's investment activity reflects direct equity and equity-linked transactions in operating businesses, not a fund-of-funds model.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: